Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

biomarker

  • Open Access
    Antitumor effects of STING agonists on nervous system tumors via tumor-intrinsic STING-STAT1-mediated HMGN2 expression
    Zijian Lv, Tiance Wang, Runjia Fan, Qianyi Ming, Jiejie Liu, Yulin Jia, Yan Zhang, Meixia Chen, Wei Chen, Zhengfan Jiang, Weidong Han and Qian Mei
    Cancer Biology & Medicine January 2026, 23 (1) 133-153; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0326
  • Open Access
    Proteomic profiling and scRNA sequencing identify signatures associated with Helicobacter pylori infection and risk of developing gastric cancer
    Yu Jin, Xue Li, Bingyao Cai, Lanxin Yang, Wenjing Zhao, Hengmin Xu, Yang Zhang, Zongchao Liu, Kaifeng Pan and Wenqing Li
    Cancer Biology & Medicine August 2025, 22 (8) 946-963; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0077
  • Open Access
    DNA damage response-related immune activation signature predicts the response to immune checkpoint inhibitors: from gastrointestinal cancer analysis to pan-cancer validation
    Junya Yan, Shibo Wang, Jing Zhang, Qiangqiang Yuan, Xianchun Gao, Nannan Zhang, Yan Pan, Haohao Zhang, Kun Liu, Jun Yu, Linbin Lu, Hui Liu, Xiaoliang Gao, Sheng Zhao, Wenyao Zhang, Abudurousuli Reyila, Yu Qi, Qiujin Zhang, Shundong Cang, Yuanyuan Lu, Yanglin Pan, Yan Kong and Yongzhan Nie
    Cancer Biology & Medicine March 2024, 21 (3) 252-266; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0303
  • You have access
    Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
    Yujiao Wang, Xi Jiao, Shuang Li, Huan Chen, Xin Wei, Chang Liu, Jifang Gong, Xiaotian Zhang, Xicheng Wang, Zhi Peng, Changsong Qi, Zhenghang Wang, Yanni Wang, Na Zhuo, Jianling Zou, Henghui Zhang, Jian Li, Lin Shen and Zhihao Lu
    Cancer Biology & Medicine August 2022, 19 (8) 1139-1149; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0708
  • You have access
    The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
    Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent and Jilong Yang
    Cancer Biology & Medicine June 2022, 19 (6) 910-930; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0270
  • You have access
    Current research on circular RNAs and their potential clinical implications in breast cancer
    Diya Liu and Lin Fang
    Cancer Biology & Medicine August 2021, 18 (3) 635-648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0275
  • You have access
    Competing endogenous RNAs in lung cancer
    Meilian Zhao, Jianguo Feng and Liling Tang
    Cancer Biology & Medicine February 2021, 18 (1) 1-20; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0203
  • You have access
    Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study
    Dongming Liu, Yi Luo, Lu Chen, Liwei Chen, Duo Zuo, Yueguo Li, Xiaofang Zhang, Jing Wu, Qing Xi, Guangtao Li, Lisha Qi, Xiaofen Yue, Xiehua Zhang, Zhuoyu Sun, Ning Zhang, Tianqiang Song, Wei Lu and Hua Guo
    Cancer Biology & Medicine February 2021, 18 (1) 256-270; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0207
  • You have access
    The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer
    Yue Fan, Haifeng Ying, Xueying Wu, Huan Chen, Ying Hu, Henghui Zhang, Lijia Wu, Ying Yang, Beibei Mao and Lan Zheng
    Cancer Biology & Medicine November 2020, 17 (4) 1002-1013; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0089
  • You have access
    MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy
    Zhe Cao, Jiangdong Qiu, Gang Yang, Yueze Liu, Wenhao Luo, Lei You, Lianfang Zheng and Taiping Zhang
    Cancer Biology & Medicine August 2020, 17 (3) 569-582; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0033

Pages

  • Next
  • 1
  • 2

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire